Successful targeting of the mouse cystic fibrosis transmembrane conductance regulator gene in embryonal stem cells. by Dorin, JR, Dickinson, P, Emslie, E, Clarke, A, Dobbie, L, Hooper, M, Halford, S, Wainwright, B, Porteous, D

CONSTRUCTION AND ANALYSIS OF LINKING LIBRARIES FROM CHROMOSOMES-11 AND XP by Pook, M, Thakrar, R, Harding, B, Porteous, D, Vanheyningen, V, Cowell, J, Jones, C, Davies, K, Thakker, R

Does a history of depression actually mediate smoking-related pain? Findings from a cross-sectional general population-based study. by van Hecke, O, Torrance, N, Cochrane, L, Cavanagh, J, Donnan, P, Padmanabhan, S, Porteous, D, Hocking, L, Smith, B

LONGITUDINAL ASSESSMENT OF BIOMARKERS FOR CLINICAL TRIALS OF NOVEL THERAPEUTIC AGENTS: THE RUN-IN STUDY by Alton, E, Boyd, C, Cunningham, S, Davies, J, Hyde, S, Ianes, J, Gill, D, Greening, A, Griesenbach, U, Higgins, T, Porteous, D

Assessment of CFTR function after gene transfer in vitro and in vivo. by Griesenbach, U, Munkonge, F, Sumner-Jones, S, Holder, E, Smith, SN, Boyd, A, Gill, DR, Hyde, S, Porteous, D, Alton, E

Mapping of retrotransposon sequences in the unstable region surrounding the spinal muscular atrophy locus in 5q13. by Francis, M, Nesbit, M, Theodosiou, A, Rodrigues, N, Campbell, L, Christodoulou, Z, Qureshi, S, Porteous, D, Brookes, A, Davies, K

A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis by Alton, E, Boyd, A, Cheng, S, Cunningham, S, Davies, J, Gill, DR, Griesenbach, U, Higgins, T, Hyde, S, Innes, J, Murray, G, Porteous, D

EVALUATION OF SAFETY AND GENE EXPRESSION WITH A SINGLE DOSE OF PGM169/GL67A ADMINISTERED TO THE NOSE AND LUNG OF INDIVIDUALS WITH CF: THE UK CF GENE THERAPY CONSORTIUM "PILOT STUDY... by Davies, J, Gill, D, Griesenbach, U, Voase, N, Davies, G, Higgins, T, Innes, J, Boyd, C, Porteous, D, Hyde, S, Alton, E

CONSTRUCTION AND ANALYSIS OF LINKING LIBRARIES FROM CHROMOSOMES XP AND 11 by Pook, M, Thakrar, R, Pottinger, B, Harding, B, Porteous, D, Vanheyningen, V, Cowell, J, Jones, C, Davies, K, Thakker, R

EVALUATION OF SAFETY AND GENE EXPRESSION WITH A SINGLE DOSE OF PGM169/GL67A ADMINISTERED TO THE NOSE AND LUNG OF INDIVIDUALS WITH CYSTIC FIBROSIS: THE UK CF GENE THERAPY CONSORTIUM... by Davies, J, Davies, G, Voase, N, Hyde, S, Innes, A, Boyd, C, Porteous, D, Higgins, T, Griesenbach, U, Gill, D, Alton, E

A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis. by Alton, E, Boyd, A, Cheng, S, Cunningham, S, Davies, J, Gill, DR, Griesenbach, U, Higgins, T, Hyde, S, Innes, J, Murray, G, Porteous, D

SAFETY AND EXPRESSION OF A SINGLE DOSE OF LIPID-MEDIATED CFTR GENE THERAPY TO THE UPPER AND LOWER AIRWAYS OF PATIENTS WITH CYSTIC FIBROSIS by Davies, G, Davies, J, Gill, DR, Hyde, S, Boyd, C, Innes, J, Porteous, D, Cheng, S, Scheule, R, Higgins, T, Griesenbach, U, Alton, E

LONGITUDINAL ASSESSMENT OF BIOMARKERS FOR CLINICAL TRIALS OF NOVEL THERAPEUTIC AGENTS; THE RUN-IN STUDY by Alton, E, Boyd, C, Cunningham, S, Davies, J, Hyde, S, Innes, J, Gill, DR, Greening, A, Griesenbach, U, Higgins, T, Porteous, D, Consortium, UKCFGT

SAFETY AND EXPRESSION OF A SINGLE DOSE OF LIPID-MEDIATED CFTR GENE THERAPY TO THE UPPER AND LOWER AIRWAYS OF PATIENTS WITH CF by Davies, J, Davies, G, Gill, D, Hyde, S, Boyd, C, Innes, J, Porteous, D, Cheng, S, Scheule, R, Higgins, T, Griesenbach, U, Alton, E

A PHASE 2B DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF NON-VIRAL MEDIATED GENE THERAPY FOR CF by Alton, E, Boyd, A, Cheng, S, Cunningham, S, Davies, J, Gill, DR, Griesenbach, U, Higgins, T, Hyde, S, Innes, J, Porteous, D, Scheule, R, UC

EagI and NotI linking clones from human chromosomes 11 and Xp. by Pook, M, Thakrar, R, Pottinger, B, Harding, B, Porteous, D, van Heyningen, V, Cowell, J, Jones, C, Povey, S, Davies, K, Thakker, R

UPDATE ON THE UK CF GENE THERAPY CONSORTIUM MULTIDOSE, NON-VIRAL, GENE THERAPY TRIAL by Alton, E, Ashby, D, Boyd, C, Cheng, S, Cunningham, S, Davies, J, Gill, D, Griesenbach, U, Higgins, T, Hyde, S, Innes, J, Murray, G, Porteous, D

UPDATE ON THE UK CF GENE THERAPY CONSORTIUM MULTIDOSE, NON-VIRAL, GENE THERAPY TRIAL by Alton, E, Ashby, D, Boyd, C, Cheng, S, Cunningham, S, Davies, J, Gill, D, Griesenbach, U, Higgins, T, Hyde, S, Innes, J, Murray, G, Porteous, D

Chronic pain, depression and cardiovascular disease linked through a shared genetic predisposition: Analysis of a family-based cohort and twin study by van Hecke, O, Hocking, L, Torrance, N, Campbell, A, Padmanabhan, S, Porteous, D, McIntosh, A, Burri, A, Tanaka, H, Williams, F, Smith, B

Longevity of expression and levels of expression of gene therapy vectors using ovine air-liquid interface tracheal cells by Davidson, H, McLachlan, G, Wilson, A, Davies, L, Holder, E, Jones, L, Doherty, A, Gill, D, Hyde, S, Collie, D, Porteous, D, Boyd, C